Navigation Links
Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM]Bronchial Thermoplasty System
Date:9/26/2011

istent with recently published five-year data from the Asthma Intervention Research (AIR) Trial, which also demonstrated a strong long-term safety profile for the Alair[TM] Bronchial Thermoplasty System.  These data are also consistent with two-year results from the Asthma Intervention Research 2 (AIR2) Trial, which demonstrated safety and long-term persistence of effect.  Clinical results from the AIR2 Trial at one year showed 32 percent reduction in asthma attacks, 84 percent reduction in emergency room visits for respiratory symptoms, 66 percent reduction in days lost from work, school or other daily activities due to asthma and improved asthma quality of life.

The Alair[TM] Bronchial Thermoplasty System has been available in the UK since June 2011 and in other European countries since September 2011.  Initial BT cases were performed with positive results at Gartnavel General Hospital in Glasgow and Wythenshawe Hospital in Manchester.  Most recently, physicians at Odense University Hospital in Denmark have performed initial BT procedures on severe asthma patients.

BT is a bronchoscopic procedure performed under moderate sedation.  The Alair[TM] Bronchial Thermoplasty Systemdelivers thermal energy to the airway wall in a precise and controlled manner to reduce excessive airway smooth muscle.  It is designed to decrease the ability of the airways to constrict, thereby reducing the frequency and severity of asthma attacks.  Designed to complement conventional asthma drug treatments, clinical data show bronchial thermoplasty is safe and effective in the treatment of severe, persistent asthma in patients 18 years and older whose asthma is not well controlled with current medications.

Prof. Neil Thomson and Dr. Steve Bicknell at Gartnavel General Hospital were the first physicians in Eur
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients
2. New Data Analyses from Lorcaserin Phase 3 Clinical Trials to be Presented at Obesity 2011
3. Uptake Medical Receives CE Mark for InterVapor - Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema - and Announces Positive Clinical Results
4. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
5. AccuNurse Delivers Real-Time Care Plan Functionality and New Dashboard to Monitor Clinical Trends, Performance and Compliance
6. Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
7. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
8. OncoGenex Announces Completion of a Special Protocol Assessment (SPA) Amendment with the FDA Increasing Patient Eligibility for the Custirsen Phase III Prostate Cancer SATURN Clinical Trial
9. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
10. ClinStar to Present on Russias Performance as an Emerging Market in Global Clinical Trials
11. Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... results for the second quarter ended June 30, ... see encouraging advancements in the US commercialization of ... total prescriptions and estimated total per week prescriptions ... President and Chief Executive Officer. "Other recent notable ...
(Date:7/31/2014)... MONROVIA, Calif., July 31, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... quarter ended July 4, 2014 of $20.0 million, a ... quarter of 2013. On a constant currency basis, revenues ... to the second quarter of 2013.  The effect of ...
(Date:7/31/2014)... 31, 2014 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... for the quarter ended June 30, 2014. Financial ... 2014 Revenue Total revenue for the quarter ended June ... the quarter ended June 30, 2013 primarily due to IMBRUVICA ... Total revenue for the six months ended June ...
Breaking Medicine Technology:Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26
... 2010 Market Publishers Ltd informs that new in-demand ... been added to its catalogue. ... Devices 2011 . In 2010, the ... and ablation devices were valued at over $1.4 billion. ...
... Dec. 16, 2010 Solta Medical, Inc. (Nasdaq: ... tightening and a market leader in aesthetic skin treatments, today ... revolutionary Thermage and Fraxel devices that have helped to build ... device industry. The milestone reflects how much the ...
Cached Medicine Technology:New Topical Research Reports by iData Research Published by MarketPublishers.com 2New Topical Research Reports by iData Research Published by MarketPublishers.com 3Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices 2Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices 3
(Date:8/1/2014)... 01, 2014 The North America Sports Drink ... North America, with analysis and forecast of revenue. The Sports ... around $5,021.9 million in 2012 to $6,243 million by 2018, ... Browse through the TOC of the North America Sports Drink ... provided. This also provides a glimpse of the segmentation in ...
(Date:8/1/2014)... The Gerontological Society of America (GSA) ... of aging has chosen Desmond "Des" O,Neill, MA, ... Dublin and Trinity College Dublin as the 2014 recipient ... given annually, is a lectureship in geriatrics and is ... aging both in research and practice who ...
(Date:8/1/2014)... Society of America (GSA) the nation,s ... aging has chosen Madonna Harrington Meyer, PhD, ... the University of Luxembourg; and Philipp Hessel, MA, ... School of Economics and Political Science as the ... Awards. , These distinguished honors recognize insightful and ...
(Date:8/1/2014)... such as text messages, emails or voicemails is highly ... preadmission antiseptic showering regimen known to help reduce risk ... study published in the August issue of the ... Each year approximately 400,000 SSIs occur and lead to ... sources cited by study authors. To help reduce ...
(Date:8/1/2014)... 01, 2014 According to Forrester Research, more ... do so in search of information, and thanks to the ... search of information and resources on insurance specifically for the ... to take this next step in the growth of our ... Springs - Commercial Insurance Resources office. “We recognize that ...
Breaking Medicine News(10 mins):Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 4Health News:O'Neill to receive GSA's 2014 Joseph T. Freeman Award 2Health News:Harrington Meyer, Leist, Hessel, Avendano to receive GSA's 2014 Kalish awards 2Health News:Electronic reminders can help patients prevent surgical site infections 2Health News:Electronic reminders can help patients prevent surgical site infections 3Health News:DCInsurers Agent Doug King Launches a New Website 2Health News:DCInsurers Agent Doug King Launches a New Website 3
... Public Health has found that the state level rates of suicide ... ownership of firearm. ,"We found that where there ... Professor of Health Policy and Management at HSPH and lead author ... 15 leading causes of death in the U.S.; among persons less ...
... The Texas Youth Commission’s (TYC) facilities continue to reel under ... News unearthed sordid// details about the agency. , ... physical abuse of the juvenile inmates, as well as gross ... that the inmates have had to wait up to even ...
... sheer torture for your aching back too. If medication ... relief. ,Inserting fine needles into the skin ... and even moderately severe depression. ,"Acupuncture helps ... as migraines and arthrosis, but also stress and asthma," ...
... may no longer be a mantra to stay fit. ... effects// on human lifespan. ,Researchers at the ... into the benefits of commonly used vitamin supplements, including ... ,They found that vitamin supplements appeared to ...
... for head injuries at the Army Hospital at Delhi is ... a road accident in West Bengal on Saturday and is ... ,A team of top-notch specialists reviewed the minister's health in ... ,"He is able to walk around and is progressing ...
... to grips with global warming and climate change, the small ... way ahead. ,Bhutan is set to become the ... a constitutional obligation to preserve the environment, according to the ... from 24 nations of Asia gather in the Bhutanese capital ...
Cached Medicine News:Health News:Household Guns Associated With Higher Rates of Suicide in US 2Health News:Acupuncture Points Way to Relief from Many Ailments 2Health News:Recovering Pranab Mukherjee Likely to Be Discharged Tomorrow 2Health News:Bhutan Leads the World in Preserving the Environment 2
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
.90mm (20G) guillotine cutting probe with 1.4mm (17G) removable irrigation sleeve...
Medicine Products: